NCT02580084

Brief Summary

Currently, according to the TASC II consensus document (2007) and the Russian guidelines for limb ischemia treatment (2010), aorta-iliac C and D type segment lesions the open surgery is suggested.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
202

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Aug 2015

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2015

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

October 14, 2015

Completed
6 days until next milestone

First Posted

Study publicly available on registry

October 20, 2015

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2017

Completed
3.6 years until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2021

Completed
Last Updated

October 11, 2021

Status Verified

May 1, 2021

Enrollment Period

2 years

First QC Date

October 14, 2015

Last Update Submit

October 4, 2021

Conditions

Keywords

atherosclerosis of the peripheral arteriesAorta-femoral BypassHybrid InterventionIliac Arteries With Stenting and Plasty of the Common Femoral Arteryplastic arteries with lesions of the common femoral artery and deep femoral artery

Outcome Measures

Primary Outcomes (3)

  • Safety assessment in the 30-day period: clinically significant bleeding, hematoma, infection of the prosthesis, infection of the postoperative wound, lymphorrhea, renal failure, myocardial infarction, stroke, mortality, thrombosis of the operated segment

    Identification of serious adverse events requiring correction of therapy or surgery. Will be used physiological parameter and questionnaire. Classification of bleeding will be used GUSTO (Severe or moderate)

    30 days

  • Evaluation of efficiency: primary patency, secondary patency success of procedures, length of hospital stay

    If a damage confirmed by duplex is detected, repeat intervention is performed on the side of the examined segment

    30 days

  • Evaluation of efficiency: success of procedures

    Technical feasibility of the procedure

    30 days

Secondary Outcomes (5)

  • mortality

    during the whole period of observation. Observation is 36 month after surgery

  • stroke

    during the whole period of observation. Observation is 36 month after surgery

  • myocardial infarction

    during the whole period of observation. Observation is 36 month after surgery

  • limb salvage

    in the early postoperative period. Surveillance is 36 month after surgery

  • infection of the prosthesis

    during the whole period of observation. Observation is 36 month after surgery

Study Arms (2)

aorta femoral bypass

ACTIVE COMPARATOR

It is sufficient to identify only the anterior-lateral aorta surface. After heparinization the aorta is clamped above and below the anastomosis. The aorta is dissected along the anterior wall, calcium portions or mural thrombus are removed. Prosthesis is cut obliquely and anastomosis suturing starts with distal angle. Occluded at the prosthetic base jaws, aortic compressor is removed, restoring blood flow in the lower limb. Next stage is tunnel creating for jaws prosthesis conduction on hip. Ureters must remain over the prosthesis, jaw should be above the iliac arteries. After jaws prosthesis conduction on hip distal anastomosis is formed with twisting controlling. Before anastomosis completion the testing jaws and all arteries bloodletting is performed.

Procedure: Aorta femoral Bypass

hybrid intervention

EXPERIMENTAL

Iliac Arteries With Stenting and Plasty of the Common Femoral Artery

Procedure: Hybrid Intervention

Interventions

The puncture of the femoral artery general is executed and the introducer 7Fr is set. Further, the hydrophilic conductor executes a recanalization of the Vasa of iliac artery occlusion. if you cannot pass the occlusion retrograde is additional access to antegrade recanalization. Then using hydrophilic conductors, an iliac artery antegrade or retrograde recanalization of the Vasa is made. Femoral artery arteriotomy. Further execute a direct endarterectomy femoral artery and from the mouth of a hip artery. arteriotomy of the femoral artery is closed with a vascular patch use (synthetic or biological). Balloon angioplasty and stenting, iliac artery is done, the controlling angiography Closing maims.

hybrid intervention

It is sufficient to identify only the anterior-lateral aorta surface. After heparinization the aorta is clamped above and below the anastomosis. The aorta is dissected along the anterior wall, calcium portions or mural thrombus are removed. Prosthesis is cut obliquely and anastomosis suturing starts with distal angle. Occluded at the prosthetic base jaws, aortic compressor is removed, restoring blood flow in the lower limb. Next stage is tunnel creating for jaws prosthesis conduction on hip. Ureters must remain over the prosthesis, jaw should be above the iliac arteries. After jaws prosthesis conduction on hip distal anastomosis is formed with twisting controlling. Before anastomosis completion the testing jaws and all arteries bloodletting is performed.

aorta femoral bypass

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with occlusive lesions of C and D type iliac segment and steno-occlusive lesions of the common femoral artery, and with chronic lower limb ischemia (II-IV degree by Fontaine, 2-5 degree by Rutherford), age: 47-75 years old.
  • Patients who consented to participate in this study

You may not qualify if:

  • Chronic heart failure of III-IV functional class by New York Heart Association classification.
  • Patients who have suffered a stroke or myocardial infarction less than 3 months
  • Significant Steno-occlusive lesion of the contralateral side
  • Decompensated chronic "pulmonary" heart
  • Aortoarteritis
  • Severe hepatic or renal failure (bilirubin\> 35 mmol / l, glomerular filtration rate \<60 mL / min);
  • Polyvalent drug allergy
  • Cancer in the terminal stage with a life expectancy less than 6 months
  • Expressed aortic calcification tolerant to angioplasty
  • Patient refusal to participate or continue to participate in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

NRICP

Novosibirsk, 630055, Russia

Location

Related Publications (1)

  • Starodubtsev V, Mitrofanov V, Ignatenko P, Gostev A, Preece R, Rabtsun A, Saaya S, Popova I, Karpenko A. Editor's Choice - Hybrid vs. Open Surgical Reconstruction for Iliofemoral Occlusive Disease: A Prospective Randomised Trial. Eur J Vasc Endovasc Surg. 2022 Apr;63(4):557-565. doi: 10.1016/j.ejvs.2022.02.002. Epub 2022 Feb 9.

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
NETWORK
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 14, 2015

First Posted

October 20, 2015

Study Start

August 1, 2015

Primary Completion

August 1, 2017

Study Completion

March 1, 2021

Last Updated

October 11, 2021

Record last verified: 2021-05

Locations